Medtronic plc — Director's Dealing 2021

Aug 27, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2021-08-25

Reporting Person: Salmon Sean (EVP & Pres Diabetes/Cardiovasc)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-25	Ordinary Shares	M	21129	$38.81	Acquired	54458	Direct
2021-08-25	Ordinary Shares	S	21129	$134.08	Disposed	33329	Direct
2021-08-25	Ordinary Shares	M	2577	$38.81	Acquired	35906	Direct
2021-08-25	Ordinary Shares	M	4713	$38.20	Acquired	40619	Direct
2021-08-25	Ordinary Shares	S	7290	$134.09	Disposed	33329	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-25	Stock Option (Right to Buy)	$38.81	M	21129	Disposed	2022-07-30	Ordinary Shares (21129)	Direct
2021-08-25	Stock Option (Right to Buy)	$38.81	M	2577	Disposed	2022-07-30	Ordinary Shares (2577)	Direct
2021-08-25	Stock Option (Right to Buy)	$38.20	M	4713	Disposed	2022-04-30	Ordinary Shares (4713)	Direct

Footnotes

F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.05 to $134.16 inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of the grant.